Общедоступные статьи - Ted CohenПодробнее...
2 статьи недоступны нигде
Проверить
Negative control exposures in epidemiologic studies
M Lipsitch, ET Tchetgen, T Cohen
Epidemiology 23 (2), 351-352, 2012
Финансирование: Government of Spain
Проверить
Trends in Untreated Tuberculosis in Large Brazilian Cities
M Chitwood, DM Pelissari, GD Marques da Silva, P Bartholomay, ...
Available at SSRN 3556629, 2020
Финансирование: US National Institutes of Health
226 статей доступны в некоторых источниках
Проверить
Negative controls: a tool for detecting confounding and bias in observational studies
M Lipsitch, ET Tchetgen, T Cohen
Epidemiology 21 (3), 383-388, 2010
Финансирование: US National Institutes of Health
Проверить
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
CB Ford, RR Shah, MK Maeda, S Gagneux, MB Murray, T Cohen, ...
Nature genetics 45 (7), 784-790, 2013
Финансирование: US National Institutes of Health, Howard Hughes Medical Institute, Doris …
Проверить
Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020
DM Weinberger, J Chen, T Cohen, FW Crawford, F Mostashari, D Olson, ...
JAMA internal medicine 180 (10), 1336-1344, 2020
Финансирование: US National Institutes of Health, Carlsberg Foundation DK
Проверить
Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates
HE Jenkins, AW Tolman, CM Yuen, JB Parr, S Keshavjee, ...
The Lancet 383 (9928), 1572-1579, 2014
Финансирование: US National Institutes of Health
Проверить
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
HH Lin, M Murray, T Cohen, C Colijn, M Ezzati
The Lancet 372 (9648), 1473-1483, 2008
Финансирование: US National Institutes of Health
Проверить
The impact of COVID-19 on TB: a review of the data
CF McQuaid, A Vassall, T Cohen, K Fiekert, RG White
The International Journal of Tuberculosis and Lung Disease 25 (6), 436-446, 2021
Финансирование: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Проверить
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance
AL Manson, KA Cohen, T Abeel, CA Desjardins, DT Armstrong, ...
Nature genetics 49 (3), 395-402, 2017
Финансирование: US National Institutes of Health, Howard Hughes Medical Institute
Проверить
The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis
L Martinez, O Cords, CR Horsburgh, JR Andrews, C Acuna-Villaorduna, ...
The Lancet 395 (10228), 973-984, 2020
Финансирование: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Проверить
Origin and proliferation of multiple-drug resistance in bacterial pathogens
HH Chang, T Cohen, YH Grad, WP Hanage, TF O'Brien, M Lipsitch
Microbiology and Molecular Biology Reviews 79 (1), 101-116, 2015
Финансирование: US National Institutes of Health
Проверить
Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation
NA Menzies, T Cohen, HH Lin, M Murray, JA Salomon
PLoS medicine 9 (11), e1001347, 2012
Финансирование: US National Institutes of Health
Проверить
The transmission of Mycobacterium tuberculosis in high burden settings
TA Yates, PY Khan, GM Knight, JG Taylor, TD McHugh, M Lipman, ...
The Lancet infectious diseases 16 (2), 227-238, 2016
Финансирование: Bill & Melinda Gates Foundation, UK Engineering and Physical Sciences …
Проверить
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
Финансирование: US National Institutes of Health, Australian Research Council, Canadian …
Проверить
Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control
T Cohen, PD van Helden, D Wilson, C Colijn, MM McLaughlin, I Abubakar, ...
Clinical microbiology reviews 25 (4), 708-719, 2012
Финансирование: US National Institutes of Health
Проверить
Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement
N Field, T Cohen, MJ Struelens, D Palm, B Cookson, JR Glynn, V Gallo, ...
The Lancet infectious diseases 14 (4), 341-352, 2014
Финансирование: National Institute for Health Research, UK
Проверить
Drivers of tuberculosis transmission
B Mathema, JR Andrews, T Cohen, MW Borgdorff, M Behr, JR Glynn, ...
The Journal of infectious diseases 216 (suppl_6), S644-S653, 2017
Финансирование: Bill & Melinda Gates Foundation, US National Institutes of Health
Проверить
Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants
JD Goldhaber-Fiebert, CY Jeon, T Cohen, MB Murray
International journal of epidemiology 40 (2), 417-428, 2011
Финансирование: US National Institutes of Health
Проверить
Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models
RMGJ Houben, NA Menzies, T Sumner, GH Huynh, N Arinaminpathy, ...
The Lancet Global Health 4 (11), e806-e815, 2016
Финансирование: US National Science Foundation, Bill & Melinda Gates Foundation, US National …
Проверить
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ...
The Lancet Microbe 3 (4), e265-e273, 2022
Финансирование: Fundação de Amparo à Pesquisa do Estado de São Paulo, Swiss National Science …
Информация о публикациях и финансировании собрана автоматически.